Maxim Oleynikov

1.6k total citations · 1 hit paper
7 papers, 1.0k citations indexed

About

Maxim Oleynikov is a scholar working on Infectious Diseases, Molecular Biology and Neurology. According to data from OpenAlex, Maxim Oleynikov has authored 7 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Molecular Biology and 2 papers in Neurology. Recurrent topics in Maxim Oleynikov's work include SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and DNA and Nucleic Acid Chemistry (2 papers). Maxim Oleynikov is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and DNA and Nucleic Acid Chemistry (2 papers). Maxim Oleynikov collaborates with scholars based in United States, India and China. Maxim Oleynikov's co-authors include Jonathan Herskovitz, Wilson R. Blomberg, Mahmudul Hasan, Jatin Machhi, Howard E. Gendelman, Bhavesh D. Kevadiya, Milankumar Patel, Ahmed M. Senan, Linda Chang and Santhi Gorantla and has published in prestigious journals such as Nature Materials, Biomaterials and Nature Methods.

In The Last Decade

Maxim Oleynikov

6 papers receiving 1.0k citations

Hit Papers

Diagnostics for SARS-CoV-2 infections 2021 2026 2022 2024 2021 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maxim Oleynikov United States 4 631 335 315 143 71 7 1.0k
Wilson R. Blomberg United States 6 637 1.0× 337 1.0× 348 1.1× 143 1.0× 76 1.1× 8 1.1k
Milankumar Patel United States 7 638 1.0× 344 1.0× 352 1.1× 145 1.0× 80 1.1× 11 1.1k
Mahmudul Hasan United States 10 669 1.1× 355 1.1× 385 1.2× 151 1.1× 86 1.2× 18 1.2k
Kazuyasu Miyoshi Japan 7 783 1.2× 186 0.6× 208 0.7× 111 0.8× 60 0.8× 16 927
Yingzhi Liu China 14 844 1.3× 291 0.9× 367 1.2× 69 0.5× 98 1.4× 34 1.4k
Anthony Chin‐Ki Ng Hong Kong 9 1.1k 1.7× 241 0.7× 182 0.6× 120 0.8× 89 1.3× 11 1.3k
Pavithra Krishnan Hong Kong 8 915 1.5× 289 0.9× 235 0.7× 59 0.4× 62 0.9× 12 1.1k
Daisy Y.M. Ng Hong Kong 8 901 1.4× 289 0.9× 232 0.7× 58 0.4× 61 0.9× 13 1.1k
Zijiao Zou China 9 713 1.1× 210 0.6× 183 0.6× 63 0.4× 103 1.5× 11 945
Marion Le Bideau France 14 940 1.5× 209 0.6× 185 0.6× 134 0.9× 140 2.0× 23 1.3k

Countries citing papers authored by Maxim Oleynikov

Since Specialization
Citations

This map shows the geographic impact of Maxim Oleynikov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxim Oleynikov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxim Oleynikov more than expected).

Fields of papers citing papers by Maxim Oleynikov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxim Oleynikov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxim Oleynikov. The network helps show where Maxim Oleynikov may publish in the future.

Co-authorship network of co-authors of Maxim Oleynikov

This figure shows the co-authorship network connecting the top 25 collaborators of Maxim Oleynikov. A scholar is included among the top collaborators of Maxim Oleynikov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxim Oleynikov. Maxim Oleynikov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Oleynikov, Maxim, et al.. (2025). A portable poison exon for small-molecule control of mammalian gene expression. Nature Methods. 22(11). 2337–2348.
2.
Oleynikov, Maxim & Samie R. Jaffrey. (2024). RNA tertiary structure and conformational dynamics revealed by BASH MaP. eLife. 13. 3 indexed citations
3.
Oleynikov, Maxim & Samie R. Jaffrey. (2024). RNA tertiary structure and conformational dynamics revealed by BASH MaP. eLife. 13. 2 indexed citations
4.
Kevadiya, Bhavesh D., Jatin Machhi, Jonathan Herskovitz, et al.. (2021). Pharmacotherapeutics of SARS-CoV-2 Infections. Journal of Neuroimmune Pharmacology. 16(1). 12–37. 5 indexed citations
5.
Kevadiya, Bhavesh D., Jatin Machhi, Jonathan Herskovitz, et al.. (2021). Diagnostics for SARS-CoV-2 infections. Nature Materials. 20(5). 593–605. 585 indexed citations breakdown →
6.
Machhi, Jatin, Jonathan Herskovitz, Ahmed M. Senan, et al.. (2020). The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections. Journal of Neuroimmune Pharmacology. 15(3). 359–386. 406 indexed citations
7.
Mukadam, Insiya, Jatin Machhi, Jonathan Herskovitz, et al.. (2019). Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking. Biomaterials. 231. 119669–119669. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026